Par Pharmaceutical commences shipping sapropterin dihydrochloride tablets and powder for oral solution

Dr. Reddy's Laboratories launches Cinacalcet Tablets in US market

Relief Therapeutics announces supply deals with two companies for COVID-19 drug while awaiting trial data

Vertice Pharma names new director and promotes Scott Meyers to chief executive officer

Dr. Reddy's Laboratories Launches Dimethyl Fumarate Delayed-Release Capsules in the US Market

US FDA grants final approval to Cipla's abbreviated new drug application for Dimethyl Fumarate DR Capsules

Dr. Reddy's Launches Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection in the US Market

Endo commences manufacturing Novavax's potential COVID-19 vaccine

Dr. Reddy's launches Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection in US market

CEBINA Touts Positive Findings on the Potency of Azelastine, a Widely Used Anti-Histamine, as Anti-COVID-19 Approach

Medivant Healthcare donates 5,000 vials of Lidocaine to Lake Charles Memorial Hospital

Dr. Reddy's Laboratories Launches Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-Dose Syringe in the US Market

Dr. Reddy's Laboratories unveils Fulvestrant Injection in 250 mg/5 ml (50 mg/ml) per single-dose syringe in the US cancer market

Dr. Reddy's Laboratories Launches Methylphenidate Hydrochloride Extended-Release Tablets USP, in the US Market

Slayback Pharma wins FDA approval of Icatibant Injection 30 mg/3 ml (10 mg/ml)